Inventory Summary of Noxopharm Limited

Noxopharm Limited's latest annual inventory in 2024 was -2.35 Million AUD , down 0.0% from previous year.
Noxopharm Limited's latest quarterly inventory in 2024 FY was - AUD , down 0.0% from previous quarter.
Noxopharm Limited reported annual inventory of - AUD in 2023, down -100.0% from previous year.
Noxopharm Limited reported annual inventory of 1.14 Million AUD in 2022, up 268.04% from previous year.
Noxopharm Limited reported quarterly inventory of - AUD for 2024 Q3, down 0.0% from previous quarter.
Noxopharm Limited reported quarterly inventory of - AUD for 2024 Q2, down 0.0% from previous quarter.

Annual Inventory Chart of Noxopharm Limited (2024 - 2016)

Historical Annual Inventory of Noxopharm Limited (2024 - 2016)

Year	Inventory	Inventory Growth
2024	-2.35 Million AUD	0.0%
2023	- AUD	-100.0%
2022	1.14 Million AUD	268.04%
2021	311.51 Thousand AUD	-40.01%
2020	519.22 Thousand AUD	-25.44%
2019	696.4 Thousand AUD	-45.12%
2018	1.26 Million AUD	0.0%
2017	- AUD	0.0%
2016	- AUD	0.0%

Year	Inventory	Inventory Growth
2024 Q4	-2.35 Million AUD	0.0%
2024 Q3	- AUD	0.0%
2024 Q2	- AUD	0.0%
2024 Q1	- AUD	0.0%
2024 FY	- AUD	0.0%
2023 Q2	1.05 Million AUD	0.0%
2023 Q4	- AUD	0.0%
2023 FY	- AUD	-100.0%
2023 Q1	1.05 Million AUD	-7.57%
2023 Q3	- AUD	-100.0%
2022 Q2	670.7 Thousand AUD	0.0%
2022 Q4	1.14 Million AUD	0.0%
2022 FY	1.14 Million AUD	268.04%
2022 Q1	670.7 Thousand AUD	115.31%
2022 Q3	1.14 Million AUD	70.94%
2021 Q1	396.61 Thousand AUD	-23.62%
2021 FY	311.51 Thousand AUD	-40.01%
2021 Q4	311.51 Thousand AUD	0.0%
2021 Q3	311.51 Thousand AUD	-21.46%
2021 Q2	396.61 Thousand AUD	0.0%
2020 Q1	574.94 Thousand AUD	-17.44%
2020 Q3	519.22 Thousand AUD	-9.69%
2020 Q2	574.94 Thousand AUD	0.0%
2020 FY	519.22 Thousand AUD	-25.44%
2020 Q4	519.22 Thousand AUD	0.0%
2019 Q1	885.76 Thousand AUD	1156.37%
2019 Q2	885.76 Thousand AUD	0.0%
2019 Q3	696.4 Thousand AUD	-21.38%
2019 FY	696.4 Thousand AUD	-45.12%
2019 Q4	696.4 Thousand AUD	0.0%
2018 Q3	1.26 Million AUD	0.0%
2018 FY	1.26 Million AUD	0.0%
2018 Q1	- AUD	0.0%
2018 Q2	- AUD	0.0%
2018 Q4	70.5 Thousand AUD	-94.44%
2017 Q1	- AUD	0.0%
2017 Q4	- AUD	0.0%
2017 Q3	- AUD	0.0%
2017 FY	- AUD	0.0%
2017 Q2	- AUD	0.0%
2016 FY	- AUD	0.0%
2016 Q4	- AUD	0.0%

Peer Inventory Comparison of Noxopharm Limited

Name	Inventory	Inventory Difference
Qrons Inc.	- USD	Infinity%
Northwest Biotherapeutics, Inc.	- USD	Infinity%
Capstone Therapeutics Corp.	12.83 Million USD	118.377%
Adynxx, Inc.	- USD	Infinity%
Santhera Pharmaceuticals Holding AG	2.15 Million USD	209.681%
ProtoKinetix, Incorporated	- USD	Infinity%
BioStem Technologies, Inc.	658.67 Thousand USD	458.178%
Evofem Biosciences, Inc.	1.69 Million USD	239.024%
Skye Bioscience, Inc.	- USD	Infinity%
Rebus Holdings, Inc.	- USD	Infinity%
Arch Therapeutics, Inc.	1.36 Million USD	272.901%
Burzynski Research Institute, Inc.	- USD	Infinity%
Neon Bloom, Inc.	7938.00 USD	29820.849%
Nascent Biotech, Inc.	- USD	Infinity%
Acro Biomedical Co., Ltd.	12 Thousand USD	19760.342%
Eiger BioPharmaceuticals, Inc.	1.55 Million USD	251.622%
Nanobac Pharmaceuticals, Incorporated	10.3 Thousand USD	22998.583%
Institute of Biomedical Research Corp.	- USD	Infinity%
SQZ Biotechnologies Company	- USD	Infinity%
Intellipharmaceutics International Inc.	1.00 USD	235924200.0%
Propanc Biopharma, Inc.	- USD	Infinity%
Mesoblast Limited	1.00 USD	235924200.0%
Marizyme, Inc.	24.85 Thousand USD	9592.018%
Genus plc	89.4 Million USD	102.639%
VioQuest Pharmaceuticals, Inc.	- USD	Infinity%
Pharming Group N.V.	56.76 Million USD	104.157%
Therapeutic Solutions International, Inc.	22.57 Thousand USD	10551.143%
CNBX Pharmaceuticals Inc.	-94.61 Thousand USD	-2393.596%
Nymox Pharmaceutical Corporation	16 Thousand USD	14845.256%
ContraFect Corporation	- USD	Infinity%
PsyBio Therapeutics Corp.	- USD	Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	Infinity%
RegeneRx Biopharmaceuticals, Inc.	- USD	Infinity%
IMV Inc.	2.00 USD	117962150.0%
AXIM Biotechnologies, Inc.	- USD	Infinity%
MultiCell Technologies, Inc.	- USD	Infinity%
ONE Bio Corp.	4.5 Million USD	152.367%
Accustem Sciences Inc.	- USD	Infinity%
RVL Pharmaceuticals plc	784 Thousand USD	400.924%
Arno Therapeutics, Inc.	- USD	Infinity%
EV Biologics, Inc.	- USD	Infinity%
Q BioMed Inc.	- USD	Infinity%
Emmaus Life Sciences, Inc.	1.71 Million USD	237.887%
Mosaic ImmunoEngineering Inc.	- USD	Infinity%
Biomind Labs Inc.	- USD	Infinity%
American Oriental Bioengineering, Inc.	20.57 Million USD	111.469%
Provectus Biopharmaceuticals, Inc.	- USD	Infinity%
TetraLogic Pharmaceuticals Corporation	- USD	Infinity%
Oncotelic Therapeutics, Inc.	- USD	Infinity%
GlobeStar Therapeutics Corporation	- USD	Infinity%
THC Farmaceuticals, Inc.	- USD	Infinity%
Curative Biotechnology, Inc.	-115.62 Thousand USD	-1940.425%
GB Sciences, Inc.	- USD	Infinity%
Alpha Cognition Inc.	90.41 Thousand USD	2709.405%
HST Global, Inc.	- USD	Infinity%
CSL Limited	5.96 Billion USD	100.04%
Wesana Health Holdings Inc.	1.00 USD	235924200.0%
Halberd Corporation	- USD	Infinity%
Enzolytics Inc.	- USD	Infinity%
Agentix Corp.	- USD	Infinity%
Resverlogix Corp.	2.37 Million USD	199.504%
Nuo Therapeutics, Inc.	209.58 Thousand USD	1225.651%
MetaStat, Inc.	- USD	Infinity%
argenx SE	310.55 Million USD	100.76%
Enzon Pharmaceuticals, Inc.	- USD	Infinity%
Endonovo Therapeutics, Inc.	- USD	Infinity%
RespireRx Pharmaceuticals Inc.	- USD	Infinity%
GeneThera, Inc.	- USD	Infinity%
Inhibitor Therapeutics, Inc.	- USD	Infinity%
AVAX Technologies, Inc.	11.52 Thousand USD	20579.523%
Zenith Capital Corp.	3.00 USD	78641466.667%
Genscript Biotech Corporation	53.33 Million USD	104.424%
Ember Therapeutics, Inc.	- USD	Infinity%
Anthera Pharmaceuticals, Inc.	- USD	Infinity%
Sigyn Therapeutics, Inc.	50 Thousand USD	4818.482%
WPD Pharmaceuticals Inc.	0.25 USD	943696500.0%
Cotinga Pharmaceuticals Inc.	0.98 USD	240738977.551%
Kadimastem Ltd	- USD	Infinity%
Helix BioMedix, Inc.	- USD	Infinity%
VitaSpring Biomedical Co. Ltd.	- USD	Infinity%
Oncology Pharma Inc.	- USD	Infinity%
Reve Technologies, Inc.	- USD	Infinity%
LadRx Corporation	- USD	Infinity%
Cell Source, Inc.	- USD	Infinity%
Regen BioPharma, Inc.	- USD	Infinity%
Regen BioPharma, Inc.	- USD	Infinity%
NovAccess Global Inc.	- USD	Infinity%
Affymax, Inc.	- USD	Infinity%
Itoco Inc.	- USD	Infinity%
Rasna Therapeutics, Inc.	-20.67 Thousand USD	-11313.289%
Pathfinder Cell Therapy, Inc.	- USD	Infinity%
Mobile Lads Corp.	- USD	Infinity%
CytoDyn Inc.	- USD	Infinity%
Claritas Pharmaceuticals, Inc.	- USD	Infinity%
NDT Pharmaceuticals Inc.	- USD	Infinity%
NanoSphere Health Sciences Inc.	-8.71 USD	-27086478.645%
Alseres Pharmaceuticals, Inc.	- USD	Infinity%
SYBLEU INC	- USD	Infinity%
Advanced Proteome Therapeutics Corporation	- USD	Infinity%
ImmunoCellular Therapeutics, Ltd.	- USD	Infinity%
International Stem Cell Corporation	1.26 Million USD	286.797%
Bioxytran, Inc.	- USD	Infinity%
GlobeImmune, Inc.	- USD	Infinity%
Predictive Technology Group, Inc.	- USD	Infinity%
ProText Mobility, Inc.	15 Million USD	115.728%
Cardax, Inc.	- USD	Infinity%
VG Life Sciences Inc.	- USD	Infinity%
Kaleido Biosciences, Inc.	- USD	Infinity%
Advaxis, Inc.	- USD	Infinity%
Adhera Therapeutics, Inc.	- USD	Infinity%
RenovaCare, Inc.	- USD	Infinity%
Regnum Corp.	- USD	Infinity%
Innovation Pharmaceuticals Inc.	- USD	Infinity%
Neutra Corp.	- USD	Infinity%
Windtree Therapeutics, Inc.	- USD	Infinity%
PureTech Health plc	- USD	Infinity%
Coeptis Therapeutics, Inc.	- USD	Infinity%
IXICO plc	1.00 USD	235924200.0%
IntelGenx Technologies Corp.	71 Thousand USD	3422.875%
Gelesis Holdings, Inc.	6.86 Million USD	134.366%
CSL Limited	5.96 Billion USD	100.04%
Cellectis S.A.	1.00 USD	235924200.0%

Global Stocks Search

Noxopharm Limited (NOXOF)

Inventory Summary of Noxopharm Limited

Annual Inventory Chart of Noxopharm Limited (2024 - 2016)

Historical Annual Inventory of Noxopharm Limited (2024 - 2016)

Peer Inventory Comparison of Noxopharm Limited